Records containing: Parkinson's Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2012-10-04A Multicenter, Randomized, Double-blind Placebo Controlled Study to Assess the Effect of Rasagiline on Sleep-wake Disturbances in Patients With Parkinson's Disease (PD)
-
CLINICAL_TRIALS study record update · 2012-10-04The Effect of Exercise Training on Gait and Quality of Life in Patients With Early Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2012-10-02Exercise, Physical Function, and Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2012-09-26A Clinic-Based, Phase IIa, Double-Blind, Placebo- Controlled, Ascending-Dose, Multicentre Study of Safety, Tolerability, Efficacy and Pharmacokinetics of VR040 in Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2012-09-13A STUDY TO EVALUATE THE EFFICACY OF CJH1 [CLR4001] IN THE TREATMENT OF PARKINSON'S DISEASE
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2012-09-11An Ascending-Dose, Single-Centre Study Investigating the Safety, Tolerability, Efficacy, and Pharmacokinetics of VR040(Inhaled Apomorphine)in Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2012-09-03Efficacy and Safety of the Iron Chelator Deferiprone on Iron Overload in the Brain in Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2012-08-31Long-Term Safety Study of KW-6002 (Istradefylline) in the Treatment of Parkinson's Disease (Phase 3)
-
CLINICAL_TRIALS study record update · 2012-08-29Placebo-Controlled, Double-Blind, Parallel Group, Fixed Dose Study of KW-6002 (Istradefylline) in the Treatment of Parkinson's Disease (Phase 3)
-
CLINICAL_TRIALS study record update · 2012-08-29Placebo-Controlled , Crossover , Double-Blind Study of KW-6002(Istradefylline) in the Treatment of Parkinson's Disease. [Monotherapy]
-
CLINICAL_TRIALS study record update · 2012-08-29Placebo-controlled, Double-blind, Parallel Group, Fixed Dose Study of KW-6002 (Istradefylline) in the Treatment of Parkinson's Disease (Phase 2 Study)
-
CLINICAL_TRIALS study record update · 2012-08-17A Phase I, Single-centre, Double-blind, Randomised, Placebo-controlled, Parallel Group Study to Assess the Pharmacokinetics, Safety and Tolerability of Two Different Extended Release Formulations of Tablets of AZD3241 (300 mg) After Administration of Multiple Doses in Healthy Male and Female Volunteers
-
CLINICAL_TRIALS study record update · 2012-08-14Detection of Striatal Dopaminergic Degeneration and Neocortical Amyloid Pathology in Patients With Dementia With Lewy Bodies, Alzheimer's Disease, Parkinson's Disease, and Healthy Elderly Volunteers
-
CLINICAL_TRIALS study record update · 2012-08-09Randomized Double-blind Placebo-controlled Trial of Intravenous Amantadine on Gait Freezing in Patients With Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2012-08-08Combined STN/SNr-DBS for the Treatment of Refractory Gait Disorders in Parkinson's Disease: Design of a Two-armed Double-blind Cross-over Study
-
CLINICAL_TRIALS study record update · 2012-07-30A Single Centre, Open-label, Multiple-dose Interventional Study Investigating the Pharmacokinetic Properties of Rasagiline (Lu 00-773) in Healthy Young Chinese Men and Women
-
CLINICAL_TRIALS study record update · 2012-07-30Phase II Clinical Trial of Domperidone as a Treatment for Dopamine Agonist-induced Peripheral Edema in Patients With Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2012-07-16Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ADX48621 in the Treatment of Levodopa Induced Dyskinesia in Patients With Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2012-07-10A Double-blind, Randomised, Placebo-controlled Study of the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Oral Doses of V81444 in Healthy Male Volunteers
-
CLINICAL_TRIALS study record update · 2012-07-10Prospective Study on the Effect of External Magnetic Stimulation on Patients With Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2012-07-09D-serine Adjuvant Treatment for Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2012-06-29Phase I Study: Monitoring Levodopa-Induced Dyskinesia Using Accelerometer & Gyroscope-based Motion Detection System
-
CLINICAL_TRIALS study record update · 2012-06-22A Randomized, Double-Blind, Crossover Study Comparing the Safety and Tolerability of Two Dose Regimens of Oromucosal Fipamezole ODT in Adult Patients With Parkinson's Disease Who Are Receiving Levodopa
-
CLINICAL_TRIALS study record update · 2012-06-22Clinical Evaluation of an Specific Diet for People With Dementia Disease
-
CLINICAL_TRIALS study record update · 2012-06-11Randomized, Dose-finding Study of BF 2.649 5, 10 20 and 40 mg/d in Comparison to Placebo in Excessive Daytime Sleepiness in Parkinson's Disease Patients (PD)